Conversely, the interaction of LL-37 with FPRL-1 has also been implicated in the metastatic progression of ovarian cancer cells, via FPRL-1-mediated recruitment of mesenchymal stromal cells (MSCs) (Coffelt et al. 2009). Here, FPR2 is linked to ovarian carcinoma.